Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

Phase 3

Suspended

• Conditions: Carcinoma, Non-Small-Cell Lung
• Interventions: Radiation: Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin

• Registration Number: NCT00540280
• Lead Sponsor: King Faisal Specialist Hospital & Research Center

Brief Summary

Randomized Phase III trial of surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in clinical early stages of non-small cell lung cancer

Detailed Description

Not available

Study Timeline

• Study Start: 2003-10
• Primary Completion: 2003-10
• Study First Submitted: 2007-10-04
• Study First Submitted QC: 2007-10-04
• Study First Posted: 2007-10-05
• Status Verified: 2011-03
• Last Update Submitted: 2011-03-06
• Last Update Posted: 2011-03-08
• Study Completion: 2013-10

Recruitment & Eligibility

• Status: SUSPENDED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Patients with early stage NSCLC

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Surgery alone	Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin	Surgery alone

Primary Outcome Measures

Name	Time	Method
OS, MS, DFS	overall